Second dose vaccines were administered to volunteers within the scope of Phase-2 of the domestic Covid-19 vaccine. Phase-3 studies will begin after the results of the volunteers are reported.
In Turkey, the development of the first transition Covidien-19 vaccine candidates into human trials Kayseri Erciyes University (ERUs), 250 Phase 2 studies on volunteers, the second dose has been completed.

ERÜ within the Vaccine Research and Development Center (ERAG) and Good Clinical Practice and Research Center (IC I) by developed and with the Ministry of Health against coronavirus Turkey Institutes of Health Presidency (TÜSEB) of support Covidien-19 vaccine candidate Phase 1 study, 44 volunteers It was completed on 14 December.

Phase-2 studies of the inactive vaccine started on February 10 on 250 volunteers. The first dose administration of the volunteers in Phase-2 was completed on 13 March, after which the second dose administration was initiated.

Second dose administration in Phase-2 studies on 250 volunteers was completed today. It was learned that the results obtained from the volunteers in the Phase-2 studies were notified to the Ministry of Health, and at the end of April, the Phase-3 phase would begin.

References: https://www.ntv.com.tr/saglik/yerli-corona-virus-asisinda-faz-2-dozlari-tamamlandi,M3GtR-kKqkq6BZFOWVkwxg